Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients

Abstract Background Although the efficacy of iron sucrose (IS) and ferric carboxymaltose (FCM) in treating anemia in hemodialysis (HD) patients has been studied individually, a comparison of these two intravenous iron formulations has not yet been performed in HD patients. Methods We performed a ret...

Full description

Bibliographic Details
Main Authors: Jesse M. G. Hofman, Michele F. Eisenga, Adry Diepenbroek, Ilja M. Nolte, Bastiaan van Dam, Ralf Westerhuis, Stephan J. L. Bakker, Casper F. M. Franssen, Carlo A. J. M. Gaillard
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Nephrology
Subjects:
Ferric carboxymaltose
Iron sucrose
Hemodialysis
Iron status
ESA
Online Access:http://link.springer.com/article/10.1186/s12882-018-1045-8

Internet

http://link.springer.com/article/10.1186/s12882-018-1045-8

Similar Items